Status:

COMPLETED

In Home Assessment of Three Anti-Snoring Devices, a Cross Over Study

Lead Sponsor:

Philips Respironics

Conditions:

Snoring

Eligibility:

All Genders

21-70 years

Phase:

NA

Brief Summary

Silent Night is a solution for primary snorers to guide them to the proper anti-snoring solution. It consists of a mobile application, which had an intake questionnaire, guides users to one of three a...

Detailed Description

Silent Night is a solution for primary snorers to guide them to the proper anti-snoring solution. It consists of a mobile application, which had an intake questionnaire, guides users to one of three a...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (Snorer):
  • Adults aged 21 to 55
  • Able and willing to provide written informed consent
  • Able to read and understand English
  • History of snoring for more than 6 months (by self-report).
  • Sleep with a bed partner for at least 4 nights per week (by self-report).
  • Told by bed partner that snoring frequently disturbs his or her sleep (by self-report).
  • Have seen a dentist within 12 months (by self-report).
  • Willing to not use any anti-snoring aids that are not associated with the study (by self-report).
  • Has purchased or used or bed partner has purchased an anti-snoring product in the past (by self-report) \[These individuals may be included in the study if recruitment timeline dictates it\]
  • Exclusion Criteria (Snorer):
  • Scored higher than a 9 on the Modified Snore Scale Score (MSSS\>9)
  • Scored higher than a 6 on the OSA 50 screener (OSA50\>6)
  • The presence of physical or mental limitations that would limit the ability to use the anti-snoring solutions.
  • Any unstable medical condition like congestive heart failure, neuromuscular disease, renal failure, or cancer (as determined by self-report and reviewed by the study PI).
  • Any severe respiratory condition (like an exacerbation of Chronic Obstructive Pulmonary Disease, bronchitis, sinusitis, respiratory failure or insufficiency or patients requiring oxygen therapy).
  • Known history of Obstructive Sleep Apnea (OSA) or Central Sleep Apnea Syndrome (by self-report)
  • Only able to sleep in the supine (flat on one's back) position (by self-report).
  • Actively suffering from an upper respiratory infection (by self-report).
  • Have a planned medical or dental procedure involving the head, neck, face (eyes, ears, nose, teeth, mouth), or lungs during the trial period (by self-report).
  • Under active treatment for an active dental problem by a dentist or orthodontist
  • Have one or more of the following dental issues (by self-report)
  • Removable dentures or bridges.
  • Temporary crowns, loose teeth, loose crowns, loose fillings, or broken teeth
  • Less than 8 natural, healthy teeth in each dental arch (upper and lower teeth)
  • Dental braces
  • TemporoMandibular Joint (TMJ) issues
  • Inclusion Criteria (Bed Partner):
  • Adults aged 21 to 70
  • Able and willing to provide written informed consent
  • Able to read and understand English
  • Rates sleep disturbance caused by partner's snoring greater than or equal to 4 on a scale of 1-10
  • Rates level of snoring volume greater than or equal to 7 on a scale of 1-10
  • Willing to sleep in same room as snorer during the study period (by self -report).
  • Willing to not start any new over-the-counter or prescription sleep medication including sedatives and hypnotics during the study period (by self-report).
  • Exclusion Criteria (Bed Partner):
  • • Told by bed partner that their snoring frequently disturbs his or her sleep (by self-report).

Exclusion

    Key Trial Info

    Start Date :

    October 9 2017

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 3 2017

    Estimated Enrollment :

    58 Patients enrolled

    Trial Details

    Trial ID

    NCT03333876

    Start Date

    October 9 2017

    End Date

    December 3 2017

    Last Update

    February 15 2019

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Philips Respironics

    Murrysville, Pennsylvania, United States, 15668